SHL's Board of Directors resolved to distribute a dividend of USD 1.00 per share

Press Release

SHL's Board of Directors resolved to distribute a dividend of USD 1.00 per share

Tel Aviv / Zurich, March 18, 2019 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) ("SHL"), a leading provider and developer of advanced personal telemedicine solutions, is announcing that the Board of Directors resolved yesterday to distribute a dividend of USD 1.00 per share (excluding the dormant shares held by SHL itself and which are not entitled to dividend under Israeli law).

Ex-date:	Wednesday, April 10, 2019
Record date:	Thursday, April 11, 2019
Expected payment date:	Tuesday, April 16, 2019

Under Israeli law and the articles of association, the board of directors may declare and cause SHL to pay such dividend and no resolution of the shareholders of SHL is required. The dividend payment is subject to Israeli withholding tax at the rate of 25%.

Financial calendar

28 March 2019	Annual Report 2018 incl. Corporate Governance Report
11 July 2019	Annual General Meeting, Tel Aviv, Israel
19 September 2019	Half-year 2019 results

For further information, please contact:

Martin Meier-Pfister, IRF, phone [phone], [e-mail]

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call centre services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). For more information, please visit the web site at www.shl-telemedicine.com.

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.

Press Release (PDF)

Provider		Channel		Contact
EQS Group Ltd., Switzerland switzerland.eqs.com		newsbox.ch www.newsbox.ch		Provider/Channel related enquiries [e-mail] [phone]